Urell and Pregnancy

Not Applicable

Terminated

• Conditions: Urinary Tract Infection (UTI)
• Interventions: Dietary Supplement: URELL; Other: Placebo

• Registration Number: NCT01818180
• Lead Sponsor: Hopital Foch

Brief Summary

Evaluation of the effect of URELL consumption on the occurrence of recurrent urinary tract infection (Acute cystitis, pyelonephritis and asymptomatic bacteriuria).

Detailed Description

Not available

Study Timeline

• Study Start: 2010-05
• Primary Completion: 2012-09
• Status Verified: 2013-03
• Study First Submitted: 2013-03-19
• Study First Submitted QC: 2013-03-21
• Last Update Submitted: 2013-03-21
• Study First Posted: 2013-03-26
• Last Update Posted: 2013-03-26

Recruitment & Eligibility

• Status: TERMINATED
• Sex: Female
• Target Recruitment: 11

Inclusion Criteria

• Pregnant woman in her 4th gestational month or more, having urinary tract infection.

Read More

Exclusion Criteria

• Pregnant woman with organic or functional urinary tract malformations
• Diabetic patients
• HIV positive

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Urell	URELL	-
Placebo	Placebo	-

Primary Outcome Measures

Name	Time	Method
Recurrence of Urinary tract infections	From the 4th gestational month till the end of pregnancy (about the 40th gestational week)

Trial Locations

Locations (1)

Hôpital FOCH; 🇫🇷 Suresnes, France